Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: A morphometric study

Psychological Medicine

Volumn 44, Issue 4, 2014, Pages 845-856

  Fullana, M A ^a,b   Cardoner, N ^c,d,e   Alonso, P ^c,d,e   Subira M ^c   Lopez Sola C ^c,d,e   Pujol, J ^a   Segalas C ^c,d   Real, E ^c,d   Bossa, M ^f   Zacur, E ^f   Martinez Zalacain I ^c   Bulbena, A ^a   Menchon J M ^c,d,e   Olmos, S ^f   Soriano Mas, C ^c,d  

^a HOSPITAL DEL MAR   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Brain morphometry; Exposure therapy; Fear extinction; Neuroimaging; Obsessive compulsive disorder

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR THERAPY; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL PROTOCOL; EQUIPMENT; FEAR; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGY; PHYSIOLOGY; REINFORCEMENT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CEREBRAL CORTEX; CLINICAL PROTOCOLS; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; GYRUS CINGULI; HUMANS; IMPLOSIVE THERAPY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896471722     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713001128     Document Type: Article

References (54)

1. Abramowitz JS (2006). The psychological treatment of obsessive-compulsive disorder. Canadian Journal of Psychiatry 51, 407-416
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association; Washington, DC.
3. Arango C, Breier A, McMahon R, Carpenter Jr. WT, Buchanan RW (2003). The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. American Journal of Psychiatry 160, 1421-1427
4. Baek K, Chae JH, Jeong J (2012). The effect of repetitive transcranial magnetic stimulation on fear extinction in rats. Neuroscience 200, 159-165
5. Berry AC, Rosenfield D, Smits JA (2009). Extinction retention predicts improvement in social anxiety symptoms following exposure therapy. Depression Anxiety 26, 22-27
6. Boschen MJ, Drummond LM (2012).Community treatment of severe, refractory obsessive-compulsive disorder. Behaviour Research and Therapy 50, 203-209
7. Bouton ME (2004). Context and behavioral processes in extinction. Learning and Memory 11, 485-494
8. Bryant RA, Felmingham K, Whitford TJ, Kemp A, Hughes G, Peduto A, Williams LM (2008). Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. Journal of Psychiatry and Neuroscience 33, 142-146
9. Cardoner N, Soriano-Mas C, Pujol J, Alonso P, Harrison BJ, Deus J, Hernandez-Ribas R, Menchon JM, Vallejo J (2007). Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder. Neuroimage 38, 413-421
10. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, Bullmore E (2007). Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 62, 407-414
11. Destrieux C, Fischl B, Dale A, Halgren E (2010). Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 53, 1-15
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Inteview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). American Psychiatric Press, Inc.: Washington, DC.
13. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York
14. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van Der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355
15. Fischl B, Salat DH, van Der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM (2004). Sequence-independent segmentation of magnetic resonance images. Neuroimage 23 (Suppl. 1), S69-S84
16. Fu CH, Steiner H, Costafreda SG (2013). Predictive neural biomarkers of clinical response in Depression; a meta-Analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiology of Disease 52, 75-83
17. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989). The Yale-Brown Obsessive Compulsive Scale; I. Development, use, and reliability. Archives of General Psychiatry 46, 1006-1011
18. Goto M, Abe O, Miyati T, Inano S, Hayashi N, Aoki S, Mori H, Kabasawa H, Ino K, Yano K, Iida K, Mima K, Ohtomo K (2011). 3 Tesla MRI detects accelerated hippocampal volume reduction in postmenopausal women. Journal of Magnetic Resonance Imaging 33, 48-53
19. Graham BM, Milad MR (2011). The study of fear extinction; implications for anxiety disorders. American Journal of Psychiatry 168, 1255-1265
20. Greenberg BD, Rauch SL, Haber SN (2010). Invasive circuitry-based neurotherapeutics: Stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 35, 317-336
21. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62
22. Hartley CA, Fischl B, Phelps EA (2011). Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cerebral Cortex 21, 1954-1962
23. Hoexter MQ, Dougherty DD, Shavitt RG, D'Alcante CC, Duran FL, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC (2012). Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder. European Neuropsychopharmacology. Published online 26 July 2012. doi:10.1016/j.euroneuro.2012.06.014
24. Hofmann SG (2007). Enhancing exposure-based therapy from a translational research perspective. Behaviour Research and Therapy 45, 1987-2001
25. Hutton C, Draganski B, Ashburner J, Weiskopf N (2009). A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 48, 371-380
26. Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ (2006). Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. Journal of Neuroscience 26, 9503-9511
27. Konradi C, Heckers S (2001). Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia. Biological Psychiatry 50, 729-742
28. Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB; American Psychiatric Association (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. American Journal of Psychiatry 164, 5-53
29. Kozak M, Foa EB (1997). Mastery of your Obsessive-Compulsive Disorder. Psychological Corp.: San Antonio, TX.
30. Labate A, Cerasa A, Mula M, Mumoli L, Gioia MC, Aguglia U, Quattrone A, Gambardella A (2012). Neuroanatomic correlates of psychogenic nonepileptic seizures: A cortical thickness and VBM study. Epilepsia 53, 377-385
31. Linden DE (2008). Brain imaging and psychotherapy; methodological considerations and practical implications. European Archives of Psychiatry and Clinical Neurosciences 258 (Suppl. 5), 71-75
32. Milad MR, Furtak SC, Greenberg JL, Keshaviah A, Im JJ, Falkenstein MJ, Jenike M, Rauch SL, Wilhelm S (2013). Deficits in conditioned fear extinction in obsessivecompulsive disorder correlate to neurobiological changes in the fear circuit. Journal of the American Medical Association. Published online 17 April 2013. doi:10:1001/jama. 2010.920
33. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK (2008). Presence and acquired origin of reduced recall for fear extinction in PTSD: Results of a twin study. Journal of Psychiatric Research 42, 515-520
34. Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP, Rauch SL (2009). Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biological Psychiatry 66, 1075-1082
35. Milad MR, Quinn BT, Pitman RK, Orr SP, Fischl B, Rauch SL (2005). Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Procedings of the National Academy of Sciences USA 102, 10706-10711
36. Milad MR, Quirk GJ (2012). Fear extinction as a model for translational neuroscience: Ten years of progress. Annual Review of Psychology 63, 129-151
37. Milad MR, Rauch SL (2012). Obsessive-compulsive disorder; beyond segregated cortico-striatal pathways. Trends in Cognitive Sciences 16, 43-51
38. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry 62, 446-454
39. Norberg MM, Krystal JH, Tolin DF (2008). A metaanalysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 63, 1118-1126
40. Osuch EA, Benson BE, Luckenbaugh DA, Geraci M, Post RM, McCann U (2009). Repetitive TMS combined with exposure therapy for PTSD: A preliminary study. Journal of Anxiety Disorders 23, 54-59
41. Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J; International Treatment Refractory OCD Consortium (2002). Treatment non-response in OCD: Methodological issues and operational definitions. International Journal of Neuropsychopharmacology 5, 181-191
42. Phelps EA, Delgado MR, Nearing KI, LeDoux JE (2004). Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 43, 897-905
43. Polli FE, Wright CI, Milad MR, Dickerson BC, Vangel M, Barton JJ, Rauch SL, Manoach DS (2009). Hemispheric differences in amygdala contributions to response monitoring. Neuroreport 20, 398-402
44. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, Vallejo J (2004). Mapping structural brain alterations in obsessive-compulsive disorder. Archives of General Psychiatry 61, 720-730
45. Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72
46. Radua J, Mataix-Cols D (2009). Voxel-wise meta-Analysis of grey matter changes in obsessive-compulsive disorder. British Journal of Psychiatry 195, 393-402
47. Rauch SL, Shin LM, Phelps EA (2006). Neurocircuitry models of posttraumatic stress disorder and extinction; human neuroimaging research - past, present, and future. Biological Psychiatry 60, 376-382
48. Rotge JY, Guehl D, Dilharreguy B, Tignol J, Bioulac B, Allard M, Burbaud P, Aouizerate B (2009). Meta-Analysis of brain volume changes in obsessive-compulsive disorder. Biological Psychiatry 65, 75-83
49. Rotge JY, Langbour N, Guehl D, Bioulac B, Jaafari N, Allard M, Aouizerate B, Burbaud P (2010). Gray matter alterations in obsessive-compulsive disorder: An anatomic likelihood estimation meta-Analysis. Neuropsychopharmacology 35, 686-691
50. Shin YW, Yoo SY, Lee JK, Ha TH, Lee KJ, Lee JM, Kim IY, Kim SI, Kwon JS (2007). Cortical thinning in obsessive compulsive disorder. Human Brain Mapping 28, 1128-1135
51. Siegle GJ, Thompson WK, Collier A, Berman SR, Feldmiller J, Thase ME, Friedman ES (2012). Toward clinically useful neuroimaging in Depression treatment; prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Archives of General Psychiatry 69, 913-924
52. Sotres-Bayon F, Cain CK, LeDoux JE (2006). Brain mechanisms of fear extinction: Historical perspectives on the contribution of prefrontal cortex. Biological Psychiatry 60, 329-336
53. Venkatasubramanian G, Zutshi A, Jindal S, Srikanth SG, Kovoor JM, Kumar JK, Janardhan Reddy YC (2012). Comprehensive evaluation of cortical structure abnormalities in Drug-naive, adult patients with obsessive-compulsive disorder: A surface-based morphometry study. Journal of Psychiatric Research 46, 1161-1168
54. Zeidan MA, Igoe SA, Linnman C, Vitalo A, Levine JB, Klibanski A, Goldstein JM, Milad MR (2011). Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biological Psychiatry 70, 920-927